It is worth mentioning that the similar inhibition manner could be observed from other pancreatic cancer cell lines bearing KRas mutations [28], in support of the preferential survival inhibition effect on mutant cancer cell lines. The gene discussed is KRAS; the disease is pancreatic neoplasm.